Cargando…
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
BACKGROUND: The direct comparison of CA19.9, circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) using endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) has never been performed for the diagnosis of solid pancreatic tumours (SPTs). METHODS: We included 68 patients with a S...
Autores principales: | Sefrioui, David, Blanchard, France, Toure, Emmanuel, Basile, Paul, Beaussire, Ludivine, Dolfus, Claire, Perdrix, Anne, Paresy, Marianne, Antonietti, Michel, Iwanicki-Caron, Isabelle, Alhameedi, Raied, Lecleire, Stephane, Gangloff, Alice, Schwarz, Lilian, Clatot, Florian, Tuech, Jean-Jacques, Frébourg, Thierry, Jardin, Fabrice, Sabourin, Jean-Christophe, Sarafan-Vasseur, Nasrin, Michel, Pierre, Di Fiore, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625666/ https://www.ncbi.nlm.nih.gov/pubmed/28772284 http://dx.doi.org/10.1038/bjc.2017.250 |
Ejemplares similares
-
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
por: Allouchery, Violette, et al.
Publicado: (2018) -
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor
por: Clatot, Florian, et al.
Publicado: (2016) -
Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022) -
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer
por: Clatot, Florian, et al.
Publicado: (2020) -
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)